Pterocarpan-enriched soy leaf extract ameliorates insulin sensitivity and pancreatic β-cell proliferation in type 2 diabetic mice

Molecules

Volumn 19, Issue 11, 2014, Pages 18493-18510

  Kim, Un Hee ^a   Yoon, Jeong Hyun ^a   Li, Hua ^a   Kang, Ji Hyun ^a   Ji, Hyeon Seon ^a,b   Park, Ki Hun ^c   Shin, Dong Ha ^d   Park, Ho Yong ^a,d   Jeong, Tae Sook ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Chungnam National University   (South Korea)

^c Gyeongsang National University   (South Korea)

^d Insect Biotech Co Ltd   (South Korea)

Author keywords

Glycine max; Insulin sensitivity; Pancreas; Pterocarpans; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; PTEROCARPAN DERIVATIVE;

ANIMAL; BLOOD; CELL PROLIFERATION; CHEMISTRY; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; METABOLISM; MOUSE; PANCREAS ISLET BETA CELL; PATHOLOGY; PLANT LEAF; SOYBEAN;

ANIMALS; BLOOD GLUCOSE; CELL PROLIFERATION; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MICE; PLANT LEAVES; PTEROCARPANS; SOYBEANS;

EID: 84912128254     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules191118493     Document Type: Article

References (49)

1. Shaw, J. E.; Sicree, R. A.; Zimmet, P. Z. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract. 2010, 87, 4-14.
2. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2010, 33, S62-S69.
3. Kahn, S. E.; Hull, R. L.; Utzschneider K. M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006, 444, 840-846.
4. Donath, M. Y.; Ehses, J. A.; Maedler, K.; Schumann, D. M.; Ellingsgaard, H.; Eppler, E.; Reinecke, M. Mechanisms of β-Cell Death in Type 2 Diabetes. Diabetes 2005, 54, S108-S113.
5. Leto, D.; Saltiel, A. R. Regulation of glucose transport by insulin: Traffic control of GLUT4. Nat. Rev. Mol. Cell Biol. 2012, 13, 383-396.
6. Thong, F. S.; Dugani, C. B.; Klip, A. Turning signals on and off: GLUT4 traffic in the insulin-signaling highway. Physiology 2005, 20, 271-284.
7. Copps, K. D.; White, M. F. Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2. Diabetologia 2012, 55, 2565-2582.
8. Samuel, V. T.; Shulman, G. I. Mechanisms for insulin resistance: Common threads and missing links. Cell 2012, 148, 852-871.
9. Messina, M.; Barnes, S. The role of soy products in reducing risk of cancer. J. Natl. Cancer Inst. 1991, 83, 541-546.
10. Wu, A. H.; Yu, M. C.; Tseng, C. C.; Pike, M. C. Epidemiology of soy exposures and breast cancer risk. Br. J. Cancer 2008, 98, 9-14.
11. Nagata, C.; Takatsuka, N.; Kurisu, Y.; Shimizu, H. Decreased serum total cholesterol concentration is associated with high intake of soy products in Japanese men and women. J. Nutr. 1998, 128, 209-213.
12. Jenkins, D. J.; Mirrahimi, A.; Srichaikul, K.; Berryman, C. E.; Wang, L.; Carleton, A.; Abdulnour, S.; Sievenpiper, J. L.; Kendall, C. W.; Kris-Etherton, P. M. Soy protein reduces serum cholesterol by both intrinsic and food displacement mechanisms. J. Nutr. 2010, 140, 2302S-2311S.
13. U. S. Department of Health & Human Services, Food and Drug Administration. Food Labeling: Health Claims; Soy Protein and Coronary Heart Disease; Federal Register: Washington, DC, USA, 1999; Volume 64, pp. 57700-57733.
14. Sacks, F. M.; Lichtenstein, A.; van Horn, L.; Harris, W.; Kris-Etherton, P.; Winston, M. Soy protein, isoflavones, and cardiovascular health: An American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation 2006, 113, 1034-1044.
15. Kong, X.; Guo, M.; Hua, Y.; Cao, D.; Zhang, C. Enzymatic preparation of immunomodulating hydrolysates from soy proteins. Bioresour. Technol. 2008, 99, 8873-8879.
16. Masotti, A. I.; Buckley, N.; Champagne, C. P.; Green-Johnson, J. Immunomodulatory bioactivity of soy and milk ferments on monocyte and macrophage models. Food Res. Int. 2011, 44, 2475-2481.
17. Setchell, K. D. Phytoestrogens: The biochemistry, physiology, and implications for human health of soy isoflavones. Am. J. Clin. Nutr. 1998, 68, 1333S-1346S.
18. Ho, H. M.; Chen, R. Y.; Leung, L. K.; Chan, F. L.; Huang, Y.; Chen, Z. Y. Difference in flavonoid and isoflavone profile between soybean and soy leaf. Biomed. Pharmacother. 2002, 56, 289-295.
19. Yuk, H. J.; Lee, J. H.; Curtis-Long, M. J.; Lee, J. W.; Kim, Y. S.; Ryu, H. W.; Park, C. G.; Jeong, T. S.; Park, K. H. The most abundant polyphenol of soy leaves, coumestrol, displays potent α-glucosidase inhibitory activity. Food Chem. 2011, 126, 1057-1063.
20. Lee, J. H.; Lee, B. W.; Kim, J. H.; Jeong, T. S.; Kim, M. J.; Lee, W. S.; Park, K. H. LDL-antioxidant pterocarpans from roots of Glycine max (L.) Merr. J. Agric. Food Chem. 2006, 54, 2057-2063.
21. Yuk, H. J., Curtis-Long, M. J., Ryu, H. W.; Jang, K. C.; Seo, W. D.; Kim, J. Y.; Kang, K. Y.; Park, K. H. Pterocarpan profiles for soybean leaves at different growth stages and investigation of their glycosidase inhibitions. J. Agric. Food Chem. 2011, 59, 12683-12690.
22. Kuete, V.; Sandjo, L. P.; Kwamou, G. M.; Wiench, B.; Nkengfack, A. E.; Efferth, T. Activity of three cytotoxic isoflavonoids from Erythrina excelsa and Erythrina senegalensis (neobavaisoflavone, sigmoidin H and isoneorautenol) toward multi-factorial drug resistant cancer cells. Phytomedicine 2014, 21, 682-688.
23. Liu, S.; Hsieh, D.; Yang, Y. L.; Xu, Z.; Peto, C.; Jablons, D. M.; You, L. Coumestrol from the national cancer Institute's natural product library is a novel inhibitor of protein kinase CK2. BMC Pharmacol. Toxicol. 2013, 11, 14-36.
24. Jantaratnotai, N.; Utaisincharoen, P.; Sanvarinda, P.; Thampithak, A.; Sanvarinda, Y. Phytoestrogens mediated anti-inflammatory effect through suppression of IRF-1 and pSTAT1 expressions in lipopolysaccharide-activated microglia. Int. Immunopharmacol. 2013, 17, 483-488.
25. Larner, J.; Brautigan, D. L.; Thorner, M. O. D-chiro-inositol glycans in insulin signaling and insulin resistance. Mol. Med. 2010, 16, 543-552.
26. Kou, K.; Saisho, Y.; Sato, S.; Yamada, T.; Itoh, H. Islet number rather than silet is a major determinant of β-cell and α-cell mass in humans. J. Clin. Endocrinol. Metab. 2014, 99, 1733-1740.
27. Peyot, M. L.; Pepin, E.; Lamontagne, J.; Latour, M. G.; Zarrouki, B.; Lussier, R.; Pineda, M.; Jetton, T. L.; Madiraju, S. R.; Joly, E.; et al. Beta-cell failure in diet-induced obese mice stratified according to body weight gain: secretory dysfunction and altered islet lipid metabolism without steatosis or reduced beta-cell mass. Diabetes 2010, 59, 2178-2187.
28. Choi, M. S.; Ryu, R.; Seo, Y. R.; Jeong, T. S.; Shin, D. H.; Park, Y. B.; Kim, S. R.; Jung, U. J. The beneficial effect of soybean (Glycine max (L.) Merr.) leaf extracts in adults with prediabetes: A randomized placebo controlled trial. Food Funct. 2014, 25, 1621-1630.
29. Kim, J. E.; Jeon, S. M.; Park, K. H.; Lee, W. S.; Jeong, T. S.; McGregor, R. A.; Choi, M. S. Does Glycine max leaves or Garcinia Cambogia promote weight-loss or lower plasma cholesterol in overweight individuals: a randomized control trial. Nutr. J. 2011, 10, 94.
30. Vishwakarma, S. K.; Rahamathulla, S.; Bardia, A.; Tiwari, S. K.; Srinivas, G.; Raj, A.; Tripura, C.; Sandhya, A.; Habeeb, M. A.; Khan, A. A.; et al. In vitro quantitative and relative gene expression analysis of pancreatic transcription factors Pdx-1, Ngn-3, Isl-1, Pax-4, Pax-6 and Nkx-6.1 in trans-differentiated human hepatic progenitors. J. Diabetes Investig. 2014, 5, 492-500.
31. Kaneto, H.; Miyatsuka, T.; Fujitani, Y.; Noguchi, H.; Song, K. H.; Yoon, K. H.; Matsuoka, T. A. Role of PDX-1 and MafA as a potential therapeutic target for diabetes. Diabetes Res. Clin. Pract. 2007, 77, S127-S137.
32. Vetere, A.; Choudhary, A.; Burns, S. M.; Wagner, B. K. Targeting the pancreatic β-cell to treat diabetes. Nat. Rev. Drug Discov. 2014, 13, 278-289.
33. Al-Hasani, K.; Pfeifer, A.; Courtney, M.; Ben-Othman, N.; Gjernes, E.; Vieira, A.; Druelle, N.; Avolio, F.; Ravassard, P.; Leuckx, G.; et al. Adult duct-lining cells can reprogram into β-like cells able to counter repeated cycles of toxin-induced diabetes. Dev. Cell 2013, 26, 86-100.
34. Leibiger, I. B.; Leibiger, B.; Berggren, P. O. Insulin signaling in the pancreatic beta-cell. Annu. Rev. Nutr. 2008, 28, 233-251.
35. Bates, S. H.; Jones, R. B.; Bailey, C. J. Insulin-like effect of pinitol. Br. J. Pharmacol. 2000, 130, 1944-1948.
36. Davis, A.; Christiansen, M.; Horowitz, J. F.; Klein, S.; Hellerstein, M. K.; Ostlund, R. E., Jr. Effect of pinitol treatment on insulin action in subjects with insulin resistance. Diabetes Care 2000, 23, 1000-1005.
37. Geethan, P. K.; Prince, P. S. Antihyperlipidemic effect of D-pinitol on streptozotocin-induced diabetic Wistar rats. J. Biochem. Mol. Toxicol. 2008, 22, 220-224.
38. Kim, J. I.; Kim, J. C.; Kang, M. J.; Lee, M. S.; Kim, J. J.; Cha, I. J. Effects of pinitol isolated from soybeans on glycaemic control and cardiovascular risk factors in Korean patients with type II diabetes mellitus: a randomized controlled study. Eur. J. Clin. Nutr. 2005, 59, 456-458.
39. Sivakumar, S.; Palsamy, P.; Subramanian, S. P. Impact of D-pinitol on the attenuation of proinflammatory cytokines, hyperglycemia-mediated oxidative stress and protection of kidney tissue ultrastructure in streptozotocin-induced diabetic rats. Chem. Biol. Interact. 2010, 188, 237-245.
40. Saltiel, A. R.; Kahn, C. R. Insulin signaling and the regulation of glucose and lipid metabolism. Nature 2001, 414, 799-806.
41. Altarejos, J. Y.; Montminy, M. CREB and the CRTC co-activators: sensors for hormonal and metabolic signals. Nat. Rev. Mol. Cell Biol. 2011, 12, 141-151.
42. Matsumoto, M.; Accili, D. The tangled path to glucose production. Nat. Med. 2006, 12, 33-34.
43. Jitrapakdee, S. Transcription factors and coactivators controlling nutrient and hormonal regulation of hepatic gluconeogenesis. Int. J. Biochem. Cell Biol. 2012, 44, 33-45.
44. Olefsky, J. M.; Glass, C. K. Macrophages, inflammation, and insulin resistance. Annu. Rev. Physiol. 2010, 72, 219-246.
45. Xu, H.; Barnes, G. T.; Yang, Q.; Tan, G.; Yang, D.; Chou, C. J.; Sole, J.; Nichols, A.; Ross, J. S.; Tartaglia, L. A.; et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Investig. 2003, 112, 1821-1830.
46. Donath, M. Y.; Shoelson, S. E. Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 2011, 11, 98-107.
47. Kristiansen, O. P.; Mandrup-Poulsen, T. Interleukin-6 and diabetes: The good, the bad, or the indifferent? Diabetes 2005, 54, S114-S124.
48. Permana, P. A.; Menge, C.; Reaven, P. D. Macrophage-secreted factors induce adipocyte inflammation and insulin resistance. Biochem. Biophys. Res. Commun. 2006, 341, 507-514.
49. Matthews, D. R.; Hosker, J. P.; Rudenski, A. S.; Naylor, B. A.; Treacher D. F.; Turner, R. C. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28, 412-419.